will see in this brief presentation, there is still room for discussing, and re-envisaging, with the use of murine models and data in humans, the concept and mechanisms of "rejection" of the foetal allograft.
But It ensues that systemic immune responses (which we do not want at all to negate, having taken a rather indisputable part in their discovery7) are, at best, a testimony of maternal recognition of the foeto-placental unit. Indeed, pregnancy is perfectly possible in the absence of humoral (antibody) response, s,9 Indeed, if tolerance to the foetus was alloantibody mediated, it would be an exception, because tolerance is MHC restricted, and the Nobel prize awarded to Zinkernagel and Doherty recognizes the consequences of that phenomenon. With rare exceptions, antibodies are not MHC restricted, and attempts to say that tolerance was antibody mediated should be in immunology history. This is not completely true, since there is not yet a satisfactory explanation of the enhancement phenomenon, possibly because of the controversy over IgG1/ IgG2 in mice, which uselessly shifted the debateenhancing antibodies in rats, are part cytotoxic.
Similarly, we do not negate, of course, the existence of systemic suppresser cells, 7 but pregnancy is perfectly viable in animals experimentally depleted of these.
T-cell-mediated immune response is simply outdated since around [1979] [1980] [1981] , and claims that unfortunately are expressed in mainstream immunology meetings and in print that "reproductive immunology has to teach the mainstream immunologists how the immune system works" as a "facilitation reaction" with "important role for enhancing antibodies.., and suppresser cells" have disastrous effects:
First, mainstream immunologists repeatedly dismiss, in a more and more irritated fashion, such preposterous advances, and, as such, would consider as a backlash the whole field as not serious; Second, those claims have led some clinicians to exacerbate the role of maternal antibodies, clouding unconsciously the issue of early pregnancy loss.
Third, they distract from the main advances that have indeed been going on, leading to molecular understanding of the field.
For indeed, there has been progress, such as Tom Wegmann's seminal idea that possibly we should re-envisage our view of the immune system in pregnancy: instead of seeing the foetus as confronted by a threat of rejection by its mother--the "immunotrophic" concept postulated from a discovery made with the routine abortion model (the CBA DBA/2 system), 11,1z we recognize that immune reaction could be in some cases beneficial for fetal survival. 13 Then, it ensued the demonstration in vitro, then in vivo, that indeed T-cell derived cytokines were growth factors for the placental trophoblasts, 14 followed by in vivo demonstration of T-cell control of placental growth ls,6 and treatment of a murine abortion model (CBA x DBA/2) by purified or recombinant cytokines.
7
In the very same period, David Clark had made the discovery that this precise model (CBA x DBA/ 2) was deficient in local, decidual associated suppresser factor, 8 and later on showed that this factor was molecularly related to We are now faced with events occurring mostly locally, and with the concept of a cytokine network at the foeto-placental interface. The events are in fact different whether one looks at parturition (where there is good evidence for involvement of interleukin [ILl-l, IL-6, IL-8, and tumor necrosis factor [TNF] e-z,zs) or the established pregnancy which is indeed immunologically characterised by transient acceptance of relatively weakly immunogenic tumor grafts of parental strain origin in the first pregnancy, linked to a T-cell anergy state and suppresser T-cell mediated multi-pregnancy induced tolerance to paternal alloantigens. [26] [27] [28] [29] In the latter case, the close examination by polymerase chain reaction (PCR) of cytokine profiles shows that it is more complicated than initially thought, with variations throughout pregnancy of which the physiological significance is yet unclear, 3 and which we will not detail here in the human. Similarly, the profiles are not simple in mice. 131 And we now come to the topic of this communication, early pregnancy. Nowhere is the understanding of the cytokine network more interesting, and nowhere has it led to more surprising discoveries, opposed to the paradigm of the acceptance of the foetal allograft, and so far away from the initial framework (which aas indeed once useful) of the facilitation reaction.
Early implantation requires "inflammatory" molecules, the consequence, in part, of a quasiinflammatory reaction locally, followed The most logical target appeared to be the maternal uterine vascular endothelial cell, since the cytokines stimulate surface expression of procoagulant (flg/2-prothrombinase, which is distinct from tissue factor) and clotting. Table 6 shows that an- or misrecognition, hence improper cytokine secretion and lack of growth factors. Several others are due to defects of the local inflammatory reaction (endometriosis, with preexisting high levels of TNF, is among these), and it is likely that, as in the LIF system, we will see discrete defects leading to definition of molecular abnormalities, with defects in adhesion molecules being involved.
Thus, early pregnancy loss and recurrent miscarriage, though due to "immunological-like" circuitry, are likely to be split up into different syndromes. It is our opinion in that respect that it is not at all surprising that only one woman out of 10 or 11 benefits from purely imunologic treatment. We have to be able to define which women will benefit by rigorous immunological criteria. (Unfortunately, the leukocyte immunisation saga has lead to many charlatan, unconscious, or preposterous theorisations, sometimes with disastrous consequences; women are not guinea pigs nor mice! We have always wondered what was the real basis for the MHC linked, disequilibrium antigen, as well as how a system like the CBA xDBA/2-which was described as minor loci dependent, MHC restricted and in which the good father (BALB/c) and the bad father (DBA/2) were both H-2d-could have been taken as an example of the proof for the need for absence of HLA homology! This is just an example, but we could--and, in fact, we are due tom write horrid things about anti-paternal antibodies, to illustrate what was said at this paper's onset.)
This has to be said, because otherwise what we learn from the discoveries of complex cytokine networks at present is that by unfounded treatments we are at risk of altering other useful pathways and induce the lack of remission of transient infertility.
The "stress" saga tells us about the importance of neuroimmunoendocrine pathways, which also should not be a surprise. 
